Global Wellness Strategies

Global Wellness Strategies operates Xtacy Therapeutics as its primary investment and operating platform in the psychedelic medicine space. Xtacy Therapeutics functions as a publicly oriented holding and development vehicle through which the firm structures its biotech bets, most notably the equity stake in Core One Labs. This centralized platform model channels capital and strategic direction through a single corporate entity rather than a diversified fund structure.

The firm's disclosed activity concentrates on psychedelic-derived treatments for mental health conditions, but its broader mandate includes wellness, digital health, and healthcare services. The primary evidence of deployment sits within regulated psychedelics, biosynthetic API production, and clinical therapy infrastructure. No positions in non-psychiatric drug classes or conventional healthcare providers have been publicly identified.

The firm's model relies on platform creation and incubation rather than third-party deal flow from a broad LP network. By structuring investments through Xtacy Therapeutics, Global Wellness Strategies can originate, build, and take public positions in biotech ventures where it can exert strategic influence. This is a concentrated, operator-led sourcing strategy native to a single-family-office or platform-holding posture, not a diversified venture scouting model.

Xctacy Therapeutics represents the only known public-facing vehicle linked to Global Wellness Strategies. The structure suggests a closed, proprietary pool of capital rather than an open-ended fund marketed to institutional limited partners. No filings or communications indicate the firm is raising capital from outside investors, making it effectively a self-funded platform rather than a traditional private equity fund.

Leadership details are not publicly disclosed. Core One Labs filings and Xtacy Therapeutics corporate records represent the closest primary sources, but neither names the individuals directing Global Wellness Strategies' investment decisions. The firm maintains an opaque governance profile common among single-investor platforms or early-stage family offices that have not opened to external capital or institutional reporting requirements.